PacBio ' s Renewed Energy

When confronted by antitrust regulators last year, the core thesis of Illumina and Pacific Biosciences was that PacBio could not survive as an independent company.   After giving up on the merger, PacBio decided to dispute their own thesis -- and seem to be succeeding so far.  As highlighted at their recent"Global Summit" meeting, they have a new CEO, new financing and a burnished product offering.Read more »
Source: Omics! Omics! - Category: Bioinformatics Authors: Source Type: blogs